Related references
Note: Only part of the references are listed.Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
Vasiliki Venetsanaki et al.
CURRENT VASCULAR PHARMACOLOGY (2019)
Lifetime Exposure to Estrogen and Progressive Supranuclear Palsy: Environmental and Genetic PSP Study
Hee Kyung Park et al.
MOVEMENT DISORDERS (2018)
Ageing, Cellular Senescence and Neurodegenerative Disease
Marios Kritsilis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Menopause and diabetes: EMAS clinical guide
Radoslaw Slopien et al.
MATURITAS (2018)
Sex and the Development of Alzheimer's Disease
Christian J. Pike
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
The relevance of gender in Parkinson's disease: a review
Marina Picillo et al.
JOURNAL OF NEUROLOGY (2017)
Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study
Bushra Irntiaz et al.
MATURITAS (2017)
Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration
Jose L. Labandeira-Garcia et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2016)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
Postmenopausal Hormone Therapy Is Not Associated With Risk of All-Cause Dementia and Alzheimers Disease
Jacqueline O'Brien et al.
EPIDEMIOLOGIC REVIEWS (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Exposure to estrogen and women's risk for Parkinson's disease: A prospective cohort study in Denmark
Kathrine Rugbjerg et al.
PARKINSONISM & RELATED DISORDERS (2013)
Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease
Y. Xing et al.
PROGRESS IN NEUROBIOLOGY (2013)
Hormone therapy and Alzheimer disease dementia New findings from the Cache County Study
Huibo Shao et al.
NEUROLOGY (2012)
Development of subtype-selective oestrogen receptor-based therapeutics
Stefan Nilsson et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause
Liqin Zhao et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Polypharmacy and Potentially Inappropriate Medication Use Among Community-dwelling Elders With Dementia
Denys T. Lau et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Influence of menopause on diabetes and diabetes risk
Emily D. Szmuilowicz et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Progesterone and estrogen regulate oxidative metabolism in brain mitochondria
Ronald W. Irwin et al.
ENDOCRINOLOGY (2008)
Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: A crossover trial
Alessandra Nicoletti et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women
Amina Yesufu et al.
WOMENS HEALTH (2007)
Postmenopausal estrogen therapy and Alzheimer disease: Overall negative findings
Rosebud O. Roberts et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2006)
Early postmenopausal hormone therapy may prevent cognitive impairment later in life
YZ Bagger et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2005)
Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age
VW Henderson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Risk of Parkinson disease in women - Effect of reproductive characteristics
P Ragonese et al.
NEUROLOGY (2004)
Postmenopausal estrogen use affects risk for Parkinson disease
LJ Currie et al.
ARCHIVES OF NEUROLOGY (2004)
Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol
RG Struble et al.
EXPERIMENTAL NEUROLOGY (2003)
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
SA Shumaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice
AD Ramirez et al.
NEUROENDOCRINOLOGY (2003)
Hormone replacement therapy and incidence of Alzheimer disease in older women - The Cache County Study
PP Zandi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease
S Seshadri et al.
ARCHIVES OF NEUROLOGY (2001)
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial
RI Mulnard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)